Back

Molecular Detection of bla OXA-48 Gene Encoding Carbapenem Resistance Pseudomonas aeruginosa Clinical Isolates from Khartoum State Hospitals, Sudan

Masaad, N. M.; Ali, D. O.

2020-06-23 genetic and genomic medicine
10.1101/2020.06.22.20137034 medRxiv
Show abstract

AbatractCarbapenem resistance in Pseudomonas.aeruginosa is particularly worrisome because this class of {beta}-lactam represents the last therapeutic resource for control of bacterial infection.So this study aimed to detect the frequency of bla OXA-48 resistance gene among Pseudomonas aeruginosa clinical isolates during the period from November 2018 to November 2019. Hundred Pseudomonas aeruginosa clinical isolates, 81 carbapenems (imipenem meropenem) resistant and 19 carbapenems sensitive were collected from Omdurman Teaching Hospital, Fedail Hospital and Soba Teaching Hospital in Khartoum State-Sudan. All isolates were re-identified using conventional bacteriological techniques, their susceptibility to carbapenems were tested using Kirby-Bauer method for confirmation and investigated for the presence of the bla OXA-48 gene using conventional PCR technique. 60 (60.0%) out of 100 Pseudomonas aeruginosa clinical isolates were positive for blaOXA-48 gene. Out of 81 carbapenem resistant isolates 54(66.7%) were positive for bla OXA-48 gene, while among the (19) carbapenem sensitive isolates 6 (31.6%) were positive for blaOXA-48 gene. There was statistically significant association between carbapenem resistant isolates and the presence of blaOXA-48 gene (P-value = 0.006). Wound swabs were the predominant clinical samples detected harboring bla OXA-48 gene both among the sensitive 5 (83.3%) and carbapenem resistant isolates 29(53.7) (P.value> 0.05). Our findings revealed high frequency of bla OXA-48 among carbapenem resistant isolates so identification of bla OXA-48 producing strains and taking efforts to reduce the rate of transferring these gene between the different strains is essential for optimization of therapy and improves of patients outcomes.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 13%
14.5%
2
Journal of Hospital Infection
27 papers in training set
Top 0.1%
10.2%
3
Genomics
60 papers in training set
Top 0.1%
9.2%
4
Pathogens
53 papers in training set
Top 0.1%
8.5%
5
Scientific Reports
3102 papers in training set
Top 14%
6.9%
6
Cureus
67 papers in training set
Top 0.6%
6.4%
50% of probability mass above
7
Heliyon
146 papers in training set
Top 0.3%
3.9%
8
Frontiers in Microbiology
375 papers in training set
Top 3%
3.6%
9
Archives of Clinical and Biomedical Research
28 papers in training set
Top 0.2%
3.6%
10
Journal of Global Antimicrobial Resistance
15 papers in training set
Top 0.2%
2.6%
11
Biomedicines
66 papers in training set
Top 0.6%
1.9%
12
Diagnostic Microbiology and Infectious Disease
21 papers in training set
Top 0.1%
1.8%
13
Antibiotics
32 papers in training set
Top 0.7%
1.8%
14
F1000Research
79 papers in training set
Top 2%
1.7%
15
Gene Reports
13 papers in training set
Top 0.4%
1.3%
16
JAC-Antimicrobial Resistance
13 papers in training set
Top 0.3%
1.3%
17
Frontiers in Molecular Biosciences
100 papers in training set
Top 3%
1.2%
18
Informatics in Medicine Unlocked
21 papers in training set
Top 0.8%
1.0%
19
Journal of Medical Virology
137 papers in training set
Top 3%
0.9%
20
Journal of Medical Microbiology
20 papers in training set
Top 0.6%
0.8%
21
Microbiology Spectrum
435 papers in training set
Top 5%
0.8%
22
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.8%
23
Journal of Bioinformatics and Systems Biology
14 papers in training set
Top 0.9%
0.7%
24
Epidemiology and Infection
84 papers in training set
Top 4%
0.7%
25
Access Microbiology
22 papers in training set
Top 0.8%
0.7%
26
International Journal of Molecular Sciences
453 papers in training set
Top 19%
0.5%
27
BioMed Research International
25 papers in training set
Top 4%
0.5%
28
BMC Genomics
328 papers in training set
Top 8%
0.5%